Where does Carl Goldfischer work?

Carl Goldfischer is Managing Director at Bay City Capital and Board director at Sidecar Therapeutics and Board director at SynGen and Board director at EnteroMedics.

What boards does Carl Goldfischer sit on?

Carl Goldfischer holds tracked board seats at Damora Therapeutics, EnteroMedics, Imara, Sidecar Therapeutics, SynGen.

Carl Goldfischer

Investor

Managing Director at Bay City Capital · Board director at Sidecar Therapeutics · Board director at SynGen · Board director at EnteroMedics

About

Carl Goldfischer is a managing director at Bay City Capital, quoted regarding the firm's participation in the Bridge Medicines partnership.

Board director at Sidecar Therapeutics

Intro paths

→

In turn, Carl can intro founders to Sidecar Therapeutics's investors below.

Sidecar Therapeutics's investors · 1

Bay City CapitalSan Rafael · $5M – $10M checks · since 2016

Board director at SynGen

Intro paths

→

In turn, Carl can intro founders to SynGen's investors below.

SynGen's investors · 1

Bay City CapitalSan Rafael · $5M – $10M checks · since 2015

Co-founders at SynGen

George BarryCo-Founder of Issuer

Philip H. CoelhoChief Technology Officer and Co-Founder of Issuer

Board director at EnteroMedics

Intro paths

→

In turn, Carl can intro founders to EnteroMedics's investors below.

EnteroMedics's investors · 1

Bay City CapitalSan Rafael · $5M – $10M checks · since 2017

Deals · 5

Damora TherapeuticsBoard seat

via Bay City Capital · filed Nov 2025 · $285M raise

ImaraBoard seat

via Bay City Capital · filed Mar 2019 · $63M raise

EnteroMedicsBoard seat

via Bay City Capital · filed Jun 2017 · $31.3M raise

Sidecar TherapeuticsBoard seat

via Bay City Capital · filed Sep 2016 · $3M raise

SynGenBoard seat

via Bay City Capital · filed Jun 2015 · $3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Bay City Capital

David Beier

Managing Director at Bay City Capital

Fred Craves

Managing Director at Bay City Capital

Larry Clay

Professional Staff at Bay City Capital

Lionel Carnot

Advisor, MS, MBA at Bay City Capital

Manuel Lopez-Figueroa

Advisor, PhD at Bay City Capital

Matthew Kronmiller

Vice President at Bay City Capital

Susan Vuong

Professional Staff at Bay City Capital

Frequently asked questions

Who is Carl Goldfischer?: Carl Goldfischer is a managing director at Bay City Capital, quoted regarding the firm's participation in the Bridge Medicines partnership.
Where does Carl Goldfischer work?: Carl Goldfischer is Managing Director at Bay City Capital and Board director at Sidecar Therapeutics and Board director at SynGen and Board director at EnteroMedics.
What boards does Carl Goldfischer sit on?: Carl Goldfischer holds tracked board seats at Damora Therapeutics, EnteroMedics, Imara, Sidecar Therapeutics, SynGen.